Histamine increases anti-CD3 induced IL-5 production of TH2-type T cells via histamine H2-receptors
- 35 Downloads
Besides its proinflammatory functions histamine released from basophils and mast cells during immediate-type hypersensitivity reactions is known to inhibit several lymphocyte functions like IL-2 and γ-IFN production. Recently, it has been shown that T helper cells of type 2 phenotype (TH2) represent the T cell fraction which may play a pivotal role in the promotion of the allergic inflammatory eosinophilic late-phase reaction by secretion of cytokines, especially IL-4 and IL-5. We have investigated the effect of histamine on anti-CD3 induced IL-4 and IL-5 production by TH2 cells. Histamine in concentrations between 10−7 and 10−5 mol/l concentration-dependently increased anti-CD3 induced IL-5 production up to 120%, whereas IL-4 production was not affected. The activity of histamine in increasing IL-5 production was mimicked by the H2-receptor agonist dimaprit. Histamine induced increase in IL-5 production was inhibited by histamine H2-receptor antagonists, but remained unaffected by H1- or H3-receptor antagonists. Administration of forskolin which directly stimulates the production of cAMP, the second messenger of the H2-receptor, also resulted in an increase in anti-CD3 induced IL-5 production. These results indicate that the histamine-mediated increase in anti-CD3 induced IL-5 production is mediated via H2-receptors. Consequently, histamine released from mast cells and basophils during the early-phase allergic reaction may act as an important stimulatory signal for the initiation of the allergic inflammatory late-phase reaction by increasing local IL-5 production of allergen triggered TH2 cells.
Key wordsT helper cells Histamine Interleukin-4 Interleukin-5
Unable to display preview. Download preview PDF.
- A. B. Kay, Sun Ying, V. A. Varney, M. Gaga, S. R. Durham, R. Moqbel, A. J. Wardlaw and Q. Hamid,Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med.173, 775–778 (1991).CrossRefPubMedGoogle Scholar
- S. R. Durham, S. Ying, V. A. Varney, M. R. Jacobsen, R. M. Sudderrick, I. S. Mackay, A. B. Kay and Q. A. Hamid,Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J. Immunol.148, 2390–2394 (1992).PubMedGoogle Scholar
- M. E. Rothenberg, J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen and W. F. Owen,IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J. Immunol.143, 2311–2316 (1989).PubMedGoogle Scholar
- J. Kaye, S. Porcelli, J. Tite, B. Jones and C. A. Janeway,Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med.158, 836–856 (1983).CrossRefPubMedGoogle Scholar
- P. Bradding, I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. A. Brews, T. C. Hunt, Y. Okayama, C. H. Heusser, G. R. Bullock, M. K. Church and S. T. Holgate,Interleukin 4 is localized to and released by human mast cells. J. Exp. Med.176, 1381–1386 (1992).CrossRefPubMedGoogle Scholar